Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs

Background: Increasing evidence supports a neuroinflammatory basis in ADHD damaging glial function and thereby altering dopaminergic (DA) neurotransmission. Previous studies focusing on the S100B protein as a marker of glial function have shown contradictory results. We conducted a clinical trial to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouadih-Moran, Miriam, Muñoz-Hoyos, Antonio, D’Marco, Luis, Molina-Carballo, Antonio, Seiquer, Isabel, Checa-Ros, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919946/
https://www.ncbi.nlm.nih.gov/pubmed/36771418
http://dx.doi.org/10.3390/nu15030712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919946/
https://www.ncbi.nlm.nih.gov/pubmed/36771418
http://dx.doi.org/10.3390/nu15030712

Ejemplares similares